| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,519 |
6,224 |
$374K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
6,200 |
3,821 |
$329K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,927 |
2,188 |
$185K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,277 |
1,580 |
$68K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,070 |
1,639 |
$64K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
657 |
459 |
$63K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,314 |
1,793 |
$49K |
| 87430 |
|
4,818 |
3,480 |
$44K |
| 87400 |
|
3,834 |
1,461 |
$37K |
| 87428 |
|
781 |
322 |
$20K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,221 |
762 |
$10K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
361 |
123 |
$10K |
| 87807 |
|
861 |
650 |
$10K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
273 |
111 |
$5K |
| 71046 |
Radiologic examination, chest; 2 views |
181 |
134 |
$3K |
| 81002 |
|
752 |
531 |
$1K |
| 81025 |
|
132 |
105 |
$694.20 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
66 |
50 |
$632.40 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
90 |
50 |
$498.39 |
| 81003 |
|
334 |
283 |
$361.92 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
28 |
12 |
$0.00 |
| A9150 |
Non-prescription drugs |
74 |
59 |
$0.00 |